Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EZH2 Antikörper (AA 353-451)

EZH2 Reaktivität: Human, Maus ChIP Wirt: Maus Monoclonal AC22 unconjugated
Produktnummer ABIN2668955
  • Target Alle EZH2 Antikörper anzeigen
    EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
    Bindungsspezifität
    • 16
    • 15
    • 15
    • 7
    • 7
    • 7
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 353-451
    Reaktivität
    • 133
    • 66
    • 34
    • 8
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 107
    • 27
    • 1
    Maus
    Klonalität
    • 99
    • 36
    Monoklonal
    Konjugat
    • 66
    • 10
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EZH2 Antikörper ist unkonjugiert
    Applikation
    • 75
    • 40
    • 36
    • 28
    • 23
    • 18
    • 14
    • 13
    • 12
    • 10
    • 7
    • 3
    • 3
    • 2
    • 2
    Chromatin Immunoprecipitation (ChIP)
    Aufreinigung
    Protein G Chromatography
    Immunogen
    This EZH2 antibody was raised against a recombinant protein corresponding to amino acids 353-451 of human EZH2.
    Klon
    AC22
    Isotyp
    IgG2a
    Top Product
    Discover our top product EZH2 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 μg/μL
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung

    Avoid repeated freeze/thaw cycles and keep on ice when not in storage.

    Lagerung
    -20 °C
    Informationen zur Lagerung
    Antibodies in solution can be stored at -20 °C for 2 years.
    Haltbarkeit
    6 months
  • Toth, Papp, Brulois, Choi, Gao, Jung: "LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005878, (2016) (PubMed).

    Ranzani, Rossetti, Panzeri, Arrigoni, Bonnal, Curti, Gruarin, Provasi, Sugliano, Marconi, De Francesco, Geginat, Bodega, Abrignani, Pagani: "The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4." in: Nature immunology, Vol. 16, Issue 3, pp. 318-325, (2015) (PubMed).

    Bengani, Mendiratta, Maini, Vasanthi, Sultana, Ghasemi, Ahluwalia, Ramachandran, Mishra, Brahmachari: "Identification and Validation of a Putative Polycomb Responsive Element in the Human Genome." in: PLoS ONE, Vol. 8, Issue 6, pp. e67217, (2013) (PubMed).

    Wang, Pan, Lee, Martinez, Feng, Dong: "Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 10, pp. 4908-12, (2013) (PubMed).

    Rossetto, Tarrant-Elorza, Pari: "Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells." in: PLoS pathogens, Vol. 9, Issue 5, pp. e1003366, (2013) (PubMed).

    Lin, Shen, Li, Tang, Gu, Chen, Hu, Rice, Lu, Wu: "Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program." in: The Journal of biological chemistry, Vol. 288, Issue 9, pp. 6238-47, (2013) (PubMed).

    Woellmer, Arteaga-Salas, Hammerschmidt: "BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression." in: PLoS pathogens, Vol. 8, Issue 9, pp. e1002902, (2012) (PubMed).

    Murata, Kondo, Sugimoto, Kawashima, Saito, Isomura, Kanda, Tsurumi: "Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells." in: Journal of virology, Vol. 86, Issue 9, pp. 4752-61, (2012) (PubMed).

  • Target
    EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
    Andere Bezeichnung
    EZH2 (EZH2 Produkte)
    Synonyme
    ENX-1 antikoerper, ENX1 antikoerper, EZH1 antikoerper, EZH2b antikoerper, KMT6 antikoerper, KMT6A antikoerper, WVS antikoerper, WVS2 antikoerper, eya2 antikoerper, im:7149338 antikoerper, zgc:136376 antikoerper, zgc:152758 antikoerper, EZH2 antikoerper, enx-1 antikoerper, enx1 antikoerper, ezh1 antikoerper, kmt6 antikoerper, xez antikoerper, Enx-1 antikoerper, Enx1h antikoerper, mKIAA4065 antikoerper, ezh2 antikoerper, olezh2 antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit L homeolog antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit S homeolog antikoerper, EZH2 antikoerper, ezh2 antikoerper, Ezh2 antikoerper, ezh2.L antikoerper, ezh2.S antikoerper
    Molekulargewicht
    96 kDa
    Gen-ID
    2146
    Pathways
    Retinoic Acid Receptor Signaling Pathway, Regulation of Muscle Cell Differentiation
Sie sind hier:
Kundenservice